These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 25446086)
1. The antitumor effects of methyl-β-cyclodextrin against primary effusion lymphoma via the depletion of cholesterol from lipid rafts. Gotoh K; Kariya R; Alam MM; Matsuda K; Hattori S; Maeda Y; Motoyama K; Kojima A; Arima H; Okada S Biochem Biophys Res Commun; 2014 Dec; 455(3-4):285-9. PubMed ID: 25446086 [TBL] [Abstract][Full Text] [Related]
2. Involvement of cholesterol depletion from lipid rafts in apoptosis induced by methyl-β-cyclodextrin. Onodera R; Motoyama K; Okamatsu A; Higashi T; Kariya R; Okada S; Arima H Int J Pharm; 2013 Aug; 452(1-2):116-23. PubMed ID: 23684659 [TBL] [Abstract][Full Text] [Related]
3. Involvement of PI3K-Akt-Bad pathway in apoptosis induced by 2,6-di-O-methyl-beta-cyclodextrin, not 2,6-di-O-methyl-alpha-cyclodextrin, through cholesterol depletion from lipid rafts on plasma membranes in cells. Motoyama K; Kameyama K; Onodera R; Araki N; Hirayama F; Uekama K; Arima H Eur J Pharm Sci; 2009 Oct; 38(3):249-61. PubMed ID: 19664706 [TBL] [Abstract][Full Text] [Related]
4. HIV protease inhibitor Lopinavir induces apoptosis of primary effusion lymphoma cells via suppression of NF-κB pathway. Kariya R; Taura M; Suzu S; Kai H; Katano H; Okada S Cancer Lett; 2014 Jan; 342(1):52-9. PubMed ID: 24012878 [TBL] [Abstract][Full Text] [Related]
5. Hybrid liposomes inhibit the growth of primary effusion lymphoma in vitro and in vivo. Towata T; Komizu Y; Suzu S; Matsumoto Y; Ueoka R; Okada S Leuk Res; 2010 Jul; 34(7):906-11. PubMed ID: 20074798 [TBL] [Abstract][Full Text] [Related]
6. Efficacy of anti-CD47 antibody-mediated phagocytosis with macrophages against primary effusion lymphoma. Goto H; Kojima Y; Matsuda K; Kariya R; Taura M; Kuwahara K; Nagai H; Katano H; Okada S Eur J Cancer; 2014 Jul; 50(10):1836-1846. PubMed ID: 24726056 [TBL] [Abstract][Full Text] [Related]
7. Potent antitumor activity of zoledronic acid-induced Vγ9Vδ2 T cells against primary effusion lymphoma. Goto H; Matsuda K; Srikoon P; Kariya R; Hattori S; Taura M; Katano H; Okada S Cancer Lett; 2013 May; 331(2):174-82. PubMed ID: 23321500 [TBL] [Abstract][Full Text] [Related]
8. Biscoclaurine alkaloid cepharanthine inhibits the growth of primary effusion lymphoma in vitro and in vivo and induces apoptosis via suppression of the NF-kappaB pathway. Takahashi-Makise N; Suzu S; Hiyoshi M; Ohsugi T; Katano H; Umezawa K; Okada S Int J Cancer; 2009 Sep; 125(6):1464-72. PubMed ID: 19521981 [TBL] [Abstract][Full Text] [Related]
9. Involvement of lipid rafts of rabbit red blood cells in morphological changes induced by methylated beta-cyclodextrins. Motoyama K; Toyodome H; Onodera R; Irie T; Hirayama F; Uekama K; Arima H Biol Pharm Bull; 2009 Apr; 32(4):700-5. PubMed ID: 19336908 [TBL] [Abstract][Full Text] [Related]
10. Supramolecular Complex of Methyl-β-cyclodextrin with Adamantane-Grafted Hyaluronic Acid as a Novel Antitumor Agent. Elamin KM; Yamashita Y; Higashi T; Motoyama K; Arima H Chem Pharm Bull (Tokyo); 2018 Mar; 66(3):277-285. PubMed ID: 29269686 [TBL] [Abstract][Full Text] [Related]
11. Induction of mitophagy-mediated antitumor activity with folate-appended methyl-β-cyclodextrin. Kameyama K; Motoyama K; Tanaka N; Yamashita Y; Higashi T; Arima H Int J Nanomedicine; 2017; 12():3433-3446. PubMed ID: 28496320 [TBL] [Abstract][Full Text] [Related]
12. Antitumor effect of berberine against primary effusion lymphoma via inhibition of NF-κB pathway. Goto H; Kariya R; Shimamoto M; Kudo E; Taura M; Katano H; Okada S Cancer Sci; 2012 Apr; 103(4):775-81. PubMed ID: 22320346 [TBL] [Abstract][Full Text] [Related]
13. Pyrrolidinium fullerene induces apoptosis by activation of procaspase-9 via suppression of Akt in primary effusion lymphoma. Watanabe T; Nakamura S; Ono T; Ui S; Yagi S; Kagawa H; Watanabe H; Ohe T; Mashino T; Fujimuro M Biochem Biophys Res Commun; 2014 Aug; 451(1):93-100. PubMed ID: 25063029 [TBL] [Abstract][Full Text] [Related]
14. Potential use of folate-appended methyl-β-cyclodextrin as an anticancer agent. Onodera R; Motoyama K; Okamatsu A; Higashi T; Arima H Sci Rep; 2013; 3():1104. PubMed ID: 23346361 [TBL] [Abstract][Full Text] [Related]
15. Targeting VEGF and interleukin-6 for controlling malignant effusion of primary effusion lymphoma. Goto H; Kudo E; Kariya R; Taura M; Katano H; Okada S J Cancer Res Clin Oncol; 2015 Mar; 141(3):465-74. PubMed ID: 25304617 [TBL] [Abstract][Full Text] [Related]
16. Folate-appended β-cyclodextrin as a promising tumor targeting carrier for antitumor drugs in vitro and in vivo. Okamatsu A; Motoyama K; Onodera R; Higashi T; Koshigoe T; Shimada Y; Hattori K; Takeuchi T; Arima H Bioconjug Chem; 2013 Apr; 24(4):724-33. PubMed ID: 23458386 [TBL] [Abstract][Full Text] [Related]
17. Tumor Targeting and Lipid Rafts Disrupting Hyaluronic Acid-Cyclodextrin-Based Nanoassembled Structure for Cancer Therapy. Lee SY; Ko SH; Shim JS; Kim DD; Cho HJ ACS Appl Mater Interfaces; 2018 Oct; 10(43):36628-36640. PubMed ID: 30298719 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of antitumor effects of folate-conjugated methyl-β-cyclodextrin in melanoma. Motoyama K; Onodera R; Tanaka N; Kameyama K; Higashi T; Kariya R; Okada S; Arima H Biol Pharm Bull; 2015; 38(3):374-9. PubMed ID: 25757918 [TBL] [Abstract][Full Text] [Related]
19. A pyridinium‑type fullerene derivative suppresses primary effusion lymphoma cell viability via the downregulation of the Wnt signaling pathway through the destabilization of β‑catenin. Kadota A; Moriguchi M; Watanabe T; Sekine Y; Nakamura S; Yasuno T; Ohe T; Mashino T; Fujimuro M Oncol Rep; 2022 Mar; 47(3):. PubMed ID: 35014678 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of HHV-8/KSHV infected primary effusion lymphomas in NOD/SCID mice by azidothymidine and interferon-alpha. Wu W; Rochford R; Toomey L; Harrington W; Feuer G Leuk Res; 2005 May; 29(5):545-55. PubMed ID: 15755507 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]